James N. Francis, Ph.D.
Affiliations: | 2012 | Biochemistry | University of Utah, Salt Lake City, UT |
Area:
BiochemistryGoogle:
"James Francis"Parents
Sign in to add mentor| Michael S. Kay | grad student | 2012 | University of Utah | |
| (Pushing the envelope: Enhancing the potency of D-peptide HIV entry inhibitors by membrane localization.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fulcher JM, Petersen ME, Giesler RJ, et al. (2019) Chemical synthesis of Shiga toxin subunit B using a next-generation traceless "helping hand" solubilizing tag. Organic & Biomolecular Chemistry |
| Smith AR, Weinstock MT, Siglin AE, et al. (2019) Characterization of resistance to a potent D-peptide HIV entry inhibitor. Retrovirology. 16: 28 |
| Redman JS, Francis JN, Marquardt R, et al. (2018) Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery. Molecular Pharmaceutics |
| Francis JN, Thaburet JF, Bonnet D, et al. (2015) Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system. Vaccine. 33: 1071-6 |
| Weinstock MT, Francis JN, Redman JS, et al. (2012) Protease-resistant peptide design-empowering nature's fragile warriors against HIV. Biopolymers. 98: 431-42 |
| Francis JN, Redman JS, Eckert DM, et al. (2012) Design of a modular tetrameric scaffold for the synthesis of membrane-localized D-peptide inhibitors of HIV-1 entry. Bioconjugate Chemistry. 23: 1252-8 |
| Welch BD, Francis JN, Redman JS, et al. (2010) Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. Journal of Virology. 84: 11235-44 |
| Francis JN, Larché M. (2005) Peptide-based vaccination: where do we stand? Current Opinion in Allergy and Clinical Immunology. 5: 537-43 |
| Francis JN, Lamont AG, Thompson SJ. (2000) The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis Immunology. 99: 338-344 |